返回
X
Xiaoyu Zhang
China Pharmaceutical University
35H指数
364论文数
5.2K被引数
收录论文 76
发表时间
Shen-Ling-Bai-Zhu-San alleviates Crohn's disease-like colitis by modulating fatty acid degradation via the peroxisome proliferation-activated receptor pathway: An integrated approach combining network pharmacology, microbiomics, metabolomics, proteomics, and experimental validation参苓白术散通过调节过氧化物增殖激活受体通路介导的脂肪酸降解来缓解克罗恩病样结肠炎:一种整合网络药理学、微生物组学、代谢组学、蛋白质组学和实验验证的综合方法
Efficacy and Safety of the Third-Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation第三代酪氨酸激酶抑制剂Olverembatinib与Inotuzumab Ozogamicin联合治疗成人费城染色体阳性急性淋巴细胞白血病患者的疗效与安全性:适用于难治/复发疾病或持续性微小残留病,作为桥接造血干细胞移植的方案。

